Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12375041rdf:typepubmed:Citationlld:pubmed
pubmed-article:12375041lifeskim:mentionsumls-concept:C0026339lld:lifeskim
pubmed-article:12375041lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:12375041lifeskim:mentionsumls-concept:C0442034lld:lifeskim
pubmed-article:12375041lifeskim:mentionsumls-concept:C0685938lld:lifeskim
pubmed-article:12375041lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:12375041lifeskim:mentionsumls-concept:C0205221lld:lifeskim
pubmed-article:12375041lifeskim:mentionsumls-concept:C0756478lld:lifeskim
pubmed-article:12375041pubmed:issue6lld:pubmed
pubmed-article:12375041pubmed:dateCreated2002-10-10lld:pubmed
pubmed-article:12375041pubmed:abstractTextWe investigated the antitumor activity of the nucleoside analog 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)cytosine (4'-thio-FAC) in peritoneal dissemination models of gastrointestinal cancers. Oral administration of 4'-thio-FAC showed a marked effect on the development of ascites and on the survival of nude mice implanted with the highly metastatic MKN-45-P gastric cancer cells into the peritoneal cavity. The toxic effect was observed at a dose of 15 mg/kg, however, no toxicity was observed at a dose of 10 mg/kg with excellent antitumor activity. We established another highly metastatic cell line HCT-15-P by serial intraperitoneal passage of the colon cancer cell line HCT-15. In the HCT-15-P model, 4'-thio-FAC showed an inhibitory effect of peritoneal dissemination and an increase in the life span at a dose of 10 mg/kg. On the other hand, oral administration of 5-fluorouracil (5-FU) and 5'-deoxy-5-fluorouridine (5'-DFUR) did not show an increase in the life span of mice at a dose of 10 mg/kg. In conclusion, 4'-thio-FAC is a promising therapeutic agent for use against peritoneal dissemination of gastrointestinal cancers.lld:pubmed
pubmed-article:12375041pubmed:languageenglld:pubmed
pubmed-article:12375041pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12375041pubmed:citationSubsetIMlld:pubmed
pubmed-article:12375041pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12375041pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12375041pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12375041pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12375041pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12375041pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12375041pubmed:statusMEDLINElld:pubmed
pubmed-article:12375041pubmed:issn1021-335Xlld:pubmed
pubmed-article:12375041pubmed:authorpubmed-author:EndoYoshioYlld:pubmed
pubmed-article:12375041pubmed:authorpubmed-author:MiuraShinjiSlld:pubmed
pubmed-article:12375041pubmed:authorpubmed-author:YonemuraYutak...lld:pubmed
pubmed-article:12375041pubmed:authorpubmed-author:SasakiTakumaTlld:pubmed
pubmed-article:12375041pubmed:authorpubmed-author:YoshimuraYuic...lld:pubmed
pubmed-article:12375041pubmed:authorpubmed-author:EndoMikariMlld:pubmed
pubmed-article:12375041pubmed:issnTypePrintlld:pubmed
pubmed-article:12375041pubmed:volume9lld:pubmed
pubmed-article:12375041pubmed:ownerNLMlld:pubmed
pubmed-article:12375041pubmed:authorsCompleteYlld:pubmed
pubmed-article:12375041pubmed:pagination1319-22lld:pubmed
pubmed-article:12375041pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12375041pubmed:meshHeadingpubmed-meshheading:12375041...lld:pubmed
pubmed-article:12375041pubmed:meshHeadingpubmed-meshheading:12375041...lld:pubmed
pubmed-article:12375041pubmed:meshHeadingpubmed-meshheading:12375041...lld:pubmed
pubmed-article:12375041pubmed:meshHeadingpubmed-meshheading:12375041...lld:pubmed
pubmed-article:12375041pubmed:meshHeadingpubmed-meshheading:12375041...lld:pubmed
pubmed-article:12375041pubmed:meshHeadingpubmed-meshheading:12375041...lld:pubmed
pubmed-article:12375041pubmed:meshHeadingpubmed-meshheading:12375041...lld:pubmed
pubmed-article:12375041pubmed:meshHeadingpubmed-meshheading:12375041...lld:pubmed
pubmed-article:12375041pubmed:meshHeadingpubmed-meshheading:12375041...lld:pubmed
pubmed-article:12375041pubmed:meshHeadingpubmed-meshheading:12375041...lld:pubmed
pubmed-article:12375041pubmed:meshHeadingpubmed-meshheading:12375041...lld:pubmed
pubmed-article:12375041pubmed:meshHeadingpubmed-meshheading:12375041...lld:pubmed
pubmed-article:12375041pubmed:meshHeadingpubmed-meshheading:12375041...lld:pubmed
pubmed-article:12375041pubmed:meshHeadingpubmed-meshheading:12375041...lld:pubmed
pubmed-article:12375041pubmed:meshHeadingpubmed-meshheading:12375041...lld:pubmed
pubmed-article:12375041pubmed:meshHeadingpubmed-meshheading:12375041...lld:pubmed
pubmed-article:12375041pubmed:meshHeadingpubmed-meshheading:12375041...lld:pubmed
pubmed-article:12375041pubmed:meshHeadingpubmed-meshheading:12375041...lld:pubmed
pubmed-article:12375041pubmed:meshHeadingpubmed-meshheading:12375041...lld:pubmed
pubmed-article:12375041pubmed:meshHeadingpubmed-meshheading:12375041...lld:pubmed
pubmed-article:12375041pubmed:meshHeadingpubmed-meshheading:12375041...lld:pubmed
pubmed-article:12375041pubmed:articleTitlePotent antitumor effect of 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)cytosine on peritoneal dissemination models of gastrointestinal cancers.lld:pubmed
pubmed-article:12375041pubmed:affiliationBiochemicals Division, Yamasa Corporation, Choshi, Chiba 288-0056, Japan. miura@yamasa.comlld:pubmed
pubmed-article:12375041pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12375041pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:12375041pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed